-
Something wrong with this record ?
Long-term trends in the incidence, treatment, hospital fatality and subsequent mortality from acute myocardial infarction in the Czech Republic
J. Bruthans, O. Mayer, J. Jarkovsky, M. Zvolsky, J. Bruthans
Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
32285848
DOI
10.5507/bp.2020.014
Knihovny.cz E-resources
- MeSH
- Incidence MeSH
- Myocardial Infarction * epidemiology MeSH
- Humans MeSH
- Morbidity MeSH
- Hospital Mortality MeSH
- Hospitals MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Czech Republic MeSH
AIMS: Studies on the incidence, acute and subsequent mortality from myocardial infarction are limited mostly to selected clinical cohorts and populations and cover relatively short periods. Our aim was to describe and analyse long-term trends on a national scale. METHODS: Acute myocardial infarction (AMI) was defined by the International Classification of Diseases (ICD)10; codes I21 and I22. Our natiowide 1994-2016 data on AMI mortality were obtained from the official mortality statistics (Czech Bureau of Statistics), data on morbidity (hospitalizations) from the National Register of Hospitalizations (Institute for Health Information and Statistics). For further analyses, data from the Czech EUROASPIRE I-V and Czech IMPACT studies were used. RESULTS: Over the 1994-2016 period the total number of AMI cases per year decreased from 34,084 to 19,015, that of patients hospitalized for AMI from 22,373 to 15,419, the total number of deaths due to AMI from 14,834 to 4,673, in those treated because of AMI from 3,794 to 1,137, and hospital fatality in patients treated for AMI decreased from 17% to 7.5%. Over the years 1997-2016, the one-year all-cause mortality rate after AMI declined from 25.1 to 17.9%, cardiovascular (CV) mortality from 22.3 to 14.2%, five-year all-cause mortality from 41.7 to 34%, and CV mortality from 34.1 to 23.6%. CONCLUSION: The Czech Republic has witnessed a pronounced decrease in AMI incidence and fatality and, consequently, long-term mortality. The decreasing incidence and improving course of AMI are due to progress in primary prevention, in acute coronary care and interventional cardiology, and in secondary coronary heart disease (CHD) prevention.
Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czech Republic
Institute of Medical Information and Statistics of the Czech Republic Prague Czech Republic
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22005990
- 003
- CZ-PrNML
- 005
- 20220310105507.0
- 007
- ta
- 008
- 220207s2021 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2020.014 $2 doi
- 035 __
- $a (PubMed)32285848
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Bruthans, Jan, $d 1948- $7 jn20000810219 $u Centre for Cardiovascular Prevention, 1st Faculty of Medicine, Charles University in Prague and Thomayer Hospital, Prague, Czech Republic $u 2nd Department of Medicine, Faculty of Medicine Pilsen, Charles University and Faculty Hospital, Pilsen, Pilsen, Czech Republic
- 245 10
- $a Long-term trends in the incidence, treatment, hospital fatality and subsequent mortality from acute myocardial infarction in the Czech Republic / $c J. Bruthans, O. Mayer, J. Jarkovsky, M. Zvolsky, J. Bruthans
- 504 __
- $a Literatura
- 520 9_
- $a AIMS: Studies on the incidence, acute and subsequent mortality from myocardial infarction are limited mostly to selected clinical cohorts and populations and cover relatively short periods. Our aim was to describe and analyse long-term trends on a national scale. METHODS: Acute myocardial infarction (AMI) was defined by the International Classification of Diseases (ICD)10; codes I21 and I22. Our natiowide 1994-2016 data on AMI mortality were obtained from the official mortality statistics (Czech Bureau of Statistics), data on morbidity (hospitalizations) from the National Register of Hospitalizations (Institute for Health Information and Statistics). For further analyses, data from the Czech EUROASPIRE I-V and Czech IMPACT studies were used. RESULTS: Over the 1994-2016 period the total number of AMI cases per year decreased from 34,084 to 19,015, that of patients hospitalized for AMI from 22,373 to 15,419, the total number of deaths due to AMI from 14,834 to 4,673, in those treated because of AMI from 3,794 to 1,137, and hospital fatality in patients treated for AMI decreased from 17% to 7.5%. Over the years 1997-2016, the one-year all-cause mortality rate after AMI declined from 25.1 to 17.9%, cardiovascular (CV) mortality from 22.3 to 14.2%, five-year all-cause mortality from 41.7 to 34%, and CV mortality from 34.1 to 23.6%. CONCLUSION: The Czech Republic has witnessed a pronounced decrease in AMI incidence and fatality and, consequently, long-term mortality. The decreasing incidence and improving course of AMI are due to progress in primary prevention, in acute coronary care and interventional cardiology, and in secondary coronary heart disease (CHD) prevention.
- 650 _2
- $a mortalita v nemocnicích $7 D017052
- 650 _2
- $a nemocnice $7 D006761
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a morbidita $7 D009017
- 650 12
- $a infarkt myokardu $x epidemiologie $7 D009203
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Mayer, Otto, $d 1969- $7 xx0053346 $u 2nd Department of Medicine, Faculty of Medicine Pilsen, Charles University and Faculty Hospital, Pilsen, Pilsen, Czech Republic
- 700 1_
- $a Jarkovský, Jiří, $d 1976- $7 stk2008461294 $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Zvolský, Miroslav $7 xx0096967 $u Institute of Medical Information and Statistics of the Czech Republic, Prague, Czech Republic
- 700 1_
- $a Bruthans, Jan, $d 1978- $7 xx0117266 $u Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University, Prague, Czech Republic
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1213-8118 $g Roč. 165, č. 3 (2021), s. 283-290
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32285848 $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c A 1502 $y p $z 0
- 990 __
- $a 20220207 $b ABA008
- 991 __
- $a 20220310105501 $b ABA008
- 999 __
- $a ok $b bmc $g 1763640 $s 1157143
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 165 $c 3 $d 283-290 $e 20200406 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK118 $a Pubmed-20220207